Fideuram Asset Management Ireland dac Invests $710,000 in MetLife, Inc. $MET

Fideuram Asset Management Ireland dac bought a new position in shares of MetLife, Inc. (NYSE:MET) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 8,505 shares of the financial services provider’s stock, valued at approximately $710,000.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Vanguard Group Inc. boosted its holdings in shares of MetLife by 12.1% during the 4th quarter. Vanguard Group Inc. now owns 72,555,335 shares of the financial services provider’s stock worth $5,727,518,000 after purchasing an additional 7,805,814 shares during the last quarter. Dodge & Cox raised its position in shares of MetLife by 0.9% during the 3rd quarter. Dodge & Cox now owns 53,659,664 shares of the financial services provider’s stock valued at $4,419,947,000 after buying an additional 477,783 shares during the period. Wellington Management Group LLP raised its position in shares of MetLife by 1.5% during the 3rd quarter. Wellington Management Group LLP now owns 12,572,807 shares of the financial services provider’s stock valued at $1,035,622,000 after buying an additional 180,683 shares during the period. Pzena Investment Management LLC raised its position in shares of MetLife by 22.9% during the 4th quarter. Pzena Investment Management LLC now owns 11,883,338 shares of the financial services provider’s stock valued at $938,071,000 after buying an additional 2,211,315 shares during the period. Finally, Ameriprise Financial Inc. raised its position in shares of MetLife by 4.8% during the 3rd quarter. Ameriprise Financial Inc. now owns 7,746,341 shares of the financial services provider’s stock valued at $640,357,000 after buying an additional 352,395 shares during the period. 94.99% of the stock is currently owned by institutional investors and hedge funds.

Trending Headlines about MetLife

Here are the key news stories impacting MetLife this week:

• Positive Sentiment: MetLife announced an expansion of its guaranteed retirement income lineup with a new flexible annuity option, which could support sales growth and reinforce its core insurance/retirement franchise. MetLife Expands Guaranteed Retirement Income Offering with Innovative Flexible Annuity Option
• Positive Sentiment: MetLife also added liquidity to an annuity product, another sign it is trying to make its retirement offerings more attractive to customers seeking flexibility and access to funds. MetLife Adds Liquidity To Annuity As Stock Trades Below Estimates
• Positive Sentiment: DOWLING & PARTN issued earnings estimates for MetLife above or near the Street for the next several years, including FY2027 EPS of $10.75 and FY2028 EPS of $12.00, reinforcing confidence in long-term profit growth.
• Neutral Sentiment: Several headlines mentioning “MetLife” were unrelated to the insurer and referred to MetLife Stadium or World Cup coverage, so they are unlikely to materially affect the stock.
• Negative Sentiment: A report that MetLife is clashing with Ares over a struggling football investment could raise some concern about a specific investment exposure, but it appears secondary to the more important product and earnings news. MetLife clashes with Ares over struggling football investment

MetLife Stock Up 1.1%

Shares of NYSE MET opened at $82.83 on Friday. The firm has a market cap of $53.29 billion, a price-to-earnings ratio of 16.05, a PEG ratio of 0.62 and a beta of 0.78. The company has a quick ratio of 0.20, a current ratio of 0.20 and a debt-to-equity ratio of 0.53. MetLife, Inc. has a 52-week low of $67.33 and a 52-week high of $85.29. The business’s 50 day moving average is $76.49 and its two-hundred day moving average is $76.85.

MetLife (NYSE:MET) last announced its earnings results on Wednesday, May 6th. The financial services provider reported $2.42 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.27 by $0.15. The company had revenue of $14.18 billion for the quarter, compared to analyst estimates of $19.49 billion. MetLife had a return on equity of 22.60% and a net margin of 4.66%.The firm’s quarterly revenue was up 2.7% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.96 earnings per share. Research analysts predict that MetLife, Inc. will post 9.96 EPS for the current year.

MetLife Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 9th. Shareholders of record on Tuesday, May 12th will be given a $0.5925 dividend. The ex-dividend date of this dividend is Tuesday, May 12th. This is a positive change from MetLife’s previous quarterly dividend of $0.57. This represents a $2.37 dividend on an annualized basis and a yield of 2.9%. MetLife’s dividend payout ratio is presently 45.93%.

Analyst Upgrades and Downgrades

MET has been the topic of several analyst reports. Bank of America reduced their price target on shares of MetLife from $103.00 to $99.00 and set a “buy” rating on the stock in a research report on Tuesday, April 14th. Barclays lifted their price target on shares of MetLife from $89.00 to $93.00 and gave the company an “overweight” rating in a research report on Thursday, May 7th. JPMorgan Chase & Co. lifted their price target on shares of MetLife from $95.00 to $96.00 and gave the company an “overweight” rating in a research report on Tuesday, May 12th. Morgan Stanley lifted their price target on shares of MetLife from $89.00 to $93.00 and gave the company an “overweight” rating in a research report on Thursday, May 21st. Finally, Evercore set a $96.00 price target on shares of MetLife in a research report on Thursday, April 9th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $95.31.

MetLife Profile

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.